DUBLIN, May 15, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/wxmjgg/biopharmaceutical) has announced the addition of the "Biopharmaceutical Contract Manufacturing Market, 2015 - 2025" report to their offering.

The Biopharmaceutical Contract Manufacturing Market, 2015 - 2025' report provides an extensive study of the contract manufacturing market for biopharmaceuticals. With biotechnology industry striving to maximize profits, outsourcing has emerged as an ever increasing trend. The study presents an in-depth analysis of a diverse set of biopharmaceutical CMOs on some of the key parameters such as geographical location, scale of operation, type of biologics manufactured, expression systems, type of bioreactors used and fermentation capacity.

In addition, it captures some of the potential growth areas which will likely present tremendous opportunities for biopharmaceutical CMOs and ensure an accelerated pace of growth. Some of the niche service areas include manufacturing of ADCs and bispecific antibodies. Specifically, these markets typify huge unmet manufacturing requirements and represent untapped areas of targeted therapy revenue making outsourcing an attractive option.

The report assesses the key drivers that have governed the evolution of biopharmaceutical contract manufacturing market over the past several years along with an elaborate discussion on the future trends that will shape the market in the coming years. One of the focus areas of this study is to estimate size of the future opportunity for biopharmaceutical CMOs market over the next decade, segmented on the basis of business operations, type of expression systems and key regions.

In addition, the study provides information on some of the most important aspects of biopharmaceutical outsourcing; these include growing collaborations, investment activity, technological advancements and development of biosimilars. In addition to some of the well-known benefits and a promising outlook, the study also highlights considerable challenges currently prevalent in the market. Examples include quality concerns, stringent regulations and lack of funding. Nevertheless, these challenges are paving the way for new strategies and technological improvements, which will indeed be advantageous in the long run.

The base year for the report is 2014; the report provides market forecasts for the period 2015 - 2025. The research, analysis and insights presented in this report is backed by a deep understanding of key insights gathered both from secondary and primary research.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Biopharmaceutical Contract Manufacturing: Developed Regions

5. Biopharmaceutical Contract Manufacturing: Emerging Regions

6. Competitive Landscape

7. Niche Sectors In Biopharmaceutical Contract Manufacturing

8. Outsourcing Of Biosimilars

9. Recent Developments

10. Market Sizing And Forecast

11. Future Of Biopharmaceutical CMO Market

12. SWOT Analysis

13. Interview Transcripts

14. Conclusion

15. Appendices

16. List Of Companies

Companies Mentioned: 30 of the 389 Companies Featured in this Extensive Report

- 3P Biopharmaceuticals
- AAIPharma Services
- ADC Biotechnology
- ADC Therapeutics
- AERAS
- AMYRA
- ARMO Biosciences
- ATMI
- AbGenomics
- AbbVie
- Ablynx
- Active Biotech
- AdAlta
- Adimab
- Affimed
- Affinicon
- Affinity Life Sciences, Inc.
- Affitech
- Agennix
- Ajinomoto Althea Inc.
- Akorn
- Aldevron
- Alethia Biotherapeutics, Inc.
- Alliance Medical Products (Siegfried)
- Alligator Bioscience
- Allozyne
- Alpax Pharmaceuticals
- Ambrx
- Amega Biotech
- Amgen

For more information visit http://www.researchandmarkets.com/research/wxmjgg/biopharmaceutical

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets